Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways
Wenle Xia, Robert J. Mullin(GlaxoSmithKline (United States)), Barry R. Keith(GlaxoSmithKline (United States)), Lei-Hua Liu(GlaxoSmithKline (United States)), Hong Ma(GlaxoSmithKline (United States)), David W. Rusnak(Research Triangle Park Foundation), Gary Owens(Research Triangle Park Foundation), Krystal J. Alligood(GlaxoSmithKline (United States)), Neil L. Spector(Research Triangle Park Foundation)
Cited by 669
Abstract
Related Papers
No related papers found
Powered by citation graph analysis